Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences, Inc.    GILD

GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Quote. Delayed Nasdaq - 10/30 04:00:00 pm
58.15 USD   -0.65%
10/29GLOBAL MARKETS LIVE: Big names today
10/29GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend
AQ
10/29GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société GILEAD SCIENCES, INC.
10/29GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend
AQ
10/29GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results
AQ
10/28GILEAD SCIENCES : View Third Quarter 2020 Earnings Slides
PU
10/28GILEAD : 3Q Earnings Snapshot
AQ
10/28GILEAD SCIENCES INC : Results of Operations and Financial Condition, Financial S..
AQ
10/28GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend
BU
10/28GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results
BU
10/26GILEAD SCIENCES : Completes Acquisition of Immunomedics, Inc.
AQ
10/26LIGAND PHARMACEUTICALS INCORPORATED : Captisol Technology Plays Key Role in the ..
AQ
10/23GILEAD SCIENCES INC : Completion of Acquisition or Disposition of Assets, Other ..
AQ
10/23Intel, American Express fall; Mattel, Boston Beer rise
AQ
10/23GILEAD SCIENCES : Anthony Welters Joins Gilead Sciences Board of Directors
AQ
10/23GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Antiviral ..
AQ
10/23Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Dire..
AQ
10/23GILEAD SCIENCES : Completes Acquisition of Immunomedics, Inc.
BU
10/22GILEAD SCIENCES : FDA approves remdesivir to treat hospitalized COVID-19 patient..
AQ
10/22FDA APPROVES FIRST COVID-19 DRUG : antiviral remdesivir
AQ
10/22FDA APPROVES FIRST COVID-19 DRUG : antiviral remdesivir
AQ
10/22GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Antiviral ..
BU
10/22GILEAD SCIENCES INC : Change in Directors or Principal Officers, Financial State..
AQ
10/22GILEAD SCIENCES : Anthony Welters Joins Gilead Sciences' Board of Directors
BU
10/22GILEAD SCIENCES : Announces New Data on Biktarvy for the Treatment of HIV in Bla..
AQ
10/21GILEAD SCIENCES : Announces New Data on Biktarvy® for the Treatment of HIV in Bl..
BU
10/20GILEAD SCIENCES : Presents New Data from Antiviral Development Programs at IDWee..
AQ
10/19GILEAD SCIENCES : European CHMP Adopts Positive Opinion for Kite's KTE-X19 for t..
AQ
10/19GILEAD SCIENCES : Presents New Data from Antiviral Development Programs at IDWee..
BU
10/16GILEAD SCIENCES : Statement on the Solidarity Trial
PU
10/16GILEAD SCIENCES : European CHMP Adopts Positive Opinion for Kite's KTE-X19 for t..
BU
10/15GILEAD SCIENCES : nbsp;Statement on the Solidarity Trial
PU
10/15GILEAD SCIENCES : to Release Third Quarter 2020 Financial Results on Wednesday, ..
AQ
10/15GILEAD SCIENCES : Announces Expiration of Hart-Scott-Rodino Waiting Period for I..
AQ
10/14GILEAD SCIENCES : to Release Third Quarter 2020 Financial Results on Wednesday, ..
BU
10/14GILEAD SCIENCES : Announces Expiration of Hart-Scott-Rodino Waiting Period for I..
BU
10/13GILEAD SCIENCES INC. : - Phase 2b/3 Trial Shows Efficacy of Filgotinib for the I..
AQ
10/09NXP, Matson rise; Advanced Micro Devices, Mallinckrodt fall
AQ
10/09GILEAD SCIENCES : Signs Joint Procurement Agreement with the European Commission..
AQ
10/09GILEAD SCIENCES : Final Results of National Institute of Allergy and Infectious ..
AQ
10/08GILEAD SCIENCES : to sell Europe 500,000 doses of remdesivir
AQ
10/08GILEAD SCIENCES : Final Results of National Institute of Allergy and Infectious ..
BU
10/08GILEAD SCIENCES : Signs Joint Procurement Agreement With the European Commission..
BU
10/06GILEAD SCIENCES : Presents Biktarvy Findings from Switch Studies and Analysis of..
AQ
10/05REGENERON PHARMACEUTICALS : What we know, and what we don't, about Trump's diagn..
AQ
10/05GILEAD SCIENCES : Presents Biktarvy® Findings From Switch Studies & Analysis of ..
BU
10/05GILEAD SCIENCES : Presents Biktarvy® Findings From Switch Studies & Analysis of ..
BU
10/05GILEAD SCIENCES : Presents Biktarvy® Findings From Switch Studies & Analysis of ..
BU
10/03GILEAD SCIENCES : Trump treated with remdesivir at Walter Reed, doctor says
AQ
10/02GILEAD SCIENCES : Update on Supply and Distribution of Veklury in the United Sta..
AQ
10/01GILEAD SCIENCES : resumes control of remdesivir distribution
AQ
10/01GILEAD SCIENCES : Update on Supply and Distribution of Veklury® (remdesivir) in ..
BU
10/01GILEAD SCIENCES : Presents Data from HIV Research and Development Programs at HI..
AQ
09/30GILEAD SCIENCES : Presents Data From HIV Research and Development Programs at HI..
BU
09/30GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Creation of a ..
AQ
09/29GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Financial Stat..
AQ
09/28Gilead Sciences, Inc. - Jyseleca Approved in Japan for Rheumatoid Arthritis
AQ
09/28GILEAD SCIENCES : European Commission Grants Marketing Authorization for Jyselec..
AQ
09/25GILEAD SCIENCES : Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthri..
BU
09/24GILEAD SCIENCES : Prices $7.25 Billion of Senior Unsecured Notes
AQ
09/23GILEAD SCIENCES : Prices $7.25 Billion of Senior Unsecured Notes
BU
09/17GILEAD SCIENCES : to acquire Immunomedics for $21 billion
AQ
09/16GILEAD SCIENCES : Magrolimab an Investigational Anti-CD47 Monoclonal Antibody, R..
AQ
09/15GILEAD SCIENCES : Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, ..
BU
09/14IMMUNOMEDICS : Wall Street posts solid gains after surge in corporate deals
AQ
09/14GILEAD SCIENCES : to Acquire Immunomedics
AQ
09/14IMMUNOMEDICS : Gilead Sciences buying Immunomedics in $21 billion deal
AQ
09/14GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Other Events, ..
AQ
09/14IMMUNOMEDICS : Gilead Sciences buying Immunomedics in $21 billion deal
AQ
09/07GILEAD SCIENCES : Company - Kite Submits Supplemental Biologics License Applicat..
AQ
09/04GILEAD SCIENCES : Kite and HiFiBiO Therapeutics Partner to Discover Novel Target..
AQ
09/04GILEAD SCIENCES : Kite Submits Supplemental Biologics License Application to U.S..
BU
09/03GILEAD SCIENCES : Kite and HiFiBiO Therapeutics Partner to Discover Novel Target..
BU
09/01GILEAD SCIENCES : FDA expands emergency use authorisation for remdesivir to trea..
AQ
08/31GILEAD SCIENCES : Investigational Antiviral Veklury Receives U.S. Food and Drug ..
AQ
08/28GILEAD SCIENCES : Investigational Antiviral Veklury® (Remdesivir) Receives U.S. ..
BU
08/26GILEAD SCIENCES : Announces Presentation of More Than 40 Abstracts from Extensiv..
AQ
08/25GILEAD SCIENCES : Announces Presentation of More Than 40 Abstracts From Extensiv..
BU
1  2  3  4  5  6  7  8  9  10Next
Official Publications
10/17SEC Filing 8K 
10/01Report 
09/30SEC Filing 8K 
09/29Report 
09/23SEC Filing 8K 
09/14SEC Filing 8K 
Upcoming event on GILEAD SCIENCES, INC.